Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report)’s share price gapped down before the market opened on Monday . The stock had previously closed at $20.95, but opened at $18.41. Ascentage Pharma Group International shares last traded at $18.11, with a volume of 6,095 shares traded.
Analyst Upgrades and Downgrades
Separately, JPMorgan Chase & Co. began coverage on Ascentage Pharma Group International in a report on Thursday, March 27th. They issued an “overweight” rating for the company.
Read Our Latest Research Report on Ascentage Pharma Group International
Ascentage Pharma Group International Price Performance
About Ascentage Pharma Group International
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Featured Articles
- Five stocks we like better than Ascentage Pharma Group International
- 3 Best Fintech Stocks for a Portfolio Boost
- Options Activity Points to More Volatility for Palantir Stock
- What Are the FAANG Stocks and Are They Good Investments?
- NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?
- What does consumer price index measure?
- MicroStrategy Sees Insider Buy-Sell Action in Q1
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
